Clinical Trials Directory

Trials / Sponsors / Theradex

Theradex

Industry · 16 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
Leukemia, Myelomonocytic, Chronic
Phase 22026-01-01
CompletedPaclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Pancreatic Cancer
Phase 22005-05-01
UnknownPixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's L
Lymphoma
Phase 22003-04-01
UnknownCombination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Lymphoma
Phase 12002-02-01
UnknownBAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Lymphoma
Phase 22002-01-01
UnknownBAY 59-8862 in Treating Patients With Advanced Kidney Cancer
Kidney Cancer
Phase 22001-12-01
UnknownDHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
Pancreatic Cancer
Phase 22001-06-01
UnknownBBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated Wit
Pancreatic Cancer
Phase 22001-05-01
UnknownDHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Colorectal Cancer
Phase 22001-05-01
UnknownDHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
Prostate Cancer
Phase 22001-04-01
UnknownChemotherapy in Treating Patients With Metastatic Kidney Cancer
Kidney Cancer
Phase 22001-04-01
UnknownPaclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
Breast Cancer
Phase 32001-01-01
UnknownBBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatm
Lung Cancer
Phase 22000-11-01
UnknownPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
Esophageal Cancer
Phase 21997-09-01
UnknownPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Head and Neck Cancer
Phase 21997-09-01
UnknownWeekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Pacli
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Phase 21997-09-01